- Home
- PSNL
PSNL
Personalis Inc.
as 05-17-2024 4:00pm EST
$.
+$.
+.%
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 72.5M | IPO Year: | 2019 |
| Target Price: | $5.00 | AVG Volume (30 days): | 298.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.90 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.89 - $2.60 | Next Earning Date: | 05-08-2024 |
| Revenue: | $74,146,000 | Revenue Growth: | 7.96% |
| Revenue Growth (this year): | 2.86% | Revenue Growth (next year): | 15.89% |
Share on Social Networks:
Stock Insider Trading Activity of Personalis Inc. (PSNL)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Moore Stephen Michael | PSNL | SVP and Chief Legal Officer | Apr 30 '24 | Sell | $1.37 | 4,523 | $6,196.51 | 72,397 | SEC Form 4 |
| Chen Richard | PSNL | CHIEF MEDICAL OFFICER AND EVP | Jan 29 '24 | Sell | $1.37 | 526 | $720.62 | 128,870 | SEC Form 4 |
| Tachibana Aaron | PSNL | CFO AND COO | Jan 29 '24 | Sell | $1.37 | 716 | $980.92 | 184,521 | SEC Form 4 |
| Tachibana Aaron | PSNL | CFO and COO | Dec 15 '23 | Sell | $1.47 | 6,747 | $9,918.09 | 185,237 | SEC Form 4 |
| Moore Stephen Michael | PSNL | General Counsel | Dec 15 '23 | Sell | $1.47 | 1,476 | $2,169.72 | 76,920 | SEC Form 4 |
| Chen Richard | PSNL | Chief Medical Officer and EVP | Dec 15 '23 | Sell | $1.47 | 4,708 | $6,920.76 | 129,396 | SEC Form 4 |
Latest Personalis Inc. News
PSNL Breaking Stock News: Dive into PSNL Ticker-Specific Updates for Smart Investing
Business Wire
10 hours ago
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Insider Monkey
9 days ago
Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript
Simply Wall St.
9 days ago
Is Personalis (NASDAQ:PSNL) In A Good Position To Deliver On Growth Plans?
Simply Wall St.
9 days ago
Personalis First Quarter 2024 Earnings: US$0.26 loss per share (vs US$0.61 loss in 1Q 2023)
Thomson Reuters StreetEvents
9 days ago
Q1 2024 Personalis Inc Earnings Call
GuruFocus.com
9 days ago
Personalis Inc (PSNL) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Revenue ...
Associated Press Finance
9 days ago
Personalis: Q1 Earnings Snapshot
Business Wire
9 days ago